Abbott Laboratories recently received FDA clearance for Tendyne, its transcatheter mitral valve replacement system. The news comes on the heels of Edwards Lifesciences Corp. securing a CE mark for its ...

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Abbott Laboratories on May 27 and set a price target of $145.00. The company’s shares closed last Wednesday at $132.02. According to ...

Visit a quote page and your recently viewed tickers will be displayed here.

Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with China and Europe and Section 232 investigations are ongoing. Nvidia, which ...